Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Uscom Ltd

UCM
Current price
0.014 AUD +0.000000000059 AUD (+0.00%)
Last closed 0.014 AUD
ISIN AU000000UCM2
Sector Healthcare
Industry Medical Devices
Exchange Australian Securities Exchange
Capitalization 3 473 079 AUD
Yield for 12 month -66.67 %
1Y
3Y
5Y
10Y
15Y
UCM
21.11.2021 - 28.11.2021

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a technology based on digital transit-time ultrasound comprising enhanced wireless and internet connectivity that allows clinicians to interface with several proprietary apps and software platforms; eHealth, which profiles cardiovascular and pulmonary function in a novel way; and respiratory devices. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia. Address: 66 Clarence Street, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.44 AUD

P/E ratio

Dividend Yield

Current Year

+3 691 135 AUD

Last Year

+2 638 639 AUD

Current Quarter

+1 998 162 AUD

Last Quarter

+1 692 971 AUD

Current Year

-393 838 AUD

Last Year

-1 015 977 AUD

Current Quarter

-221 199 AUD

Last Quarter

-172 640 AUD

Key Figures UCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 785 550 AUD
Operating Margin TTM -62.47 %
PE Ratio
Return On Assets TTM -23.53 %
PEG Ratio
Return On Equity TTM -67.97 %
Wall Street Target Price 0.44 AUD
Revenue TTM 3 691 136 AUD
Book Value 0.013 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 26 %
Dividend Yield
Gross Profit TTM 2 223 948 AUD
Earnings per share -0.0099 AUD
Diluted Eps TTM -0.0099 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -55.67 %

Dividend Analytics UCM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History UCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation UCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.5302
Price Sales TTM 0.9409
Enterprise Value EBITDA -2.7179
Price Book MRQ 1.1456

Financials UCM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators UCM

For 52 weeks

0.012 AUD 0.05 AUD
50 Day MA 0.015 AUD
Shares Short Prior Month
200 Day MA 0.026 AUD
Short Ratio
Shares Short
Short Percent